Back
Also listed as
MCVEF
OTC
Day Range
$16.55
$21.54
52-Week Range
$16.55
$21.54
Volume
100
50D / 200D Avg
$16.55
/
$16.55
Prev Close
$16.55
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 32.2 | 0.3 |
| P/B | 4.7 | 3.0 |
| ROE % | 15.5 | 3.7 |
| Net Margin % | 3.3 | 3.8 |
| Rev Growth 5Y % | 14.6 | 10.0 |
| D/E | 2.7 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2027 |
$0.00
$0.00 – $0.00
|
2.60B | 0 |
| FY2026 |
$0.00
$0.00 – $0.00
|
2.31B | 0 |
No quarterly estimates available
Earnings Surprises
Last 3 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-10 | N/A | $0.15 | — |
| 2025-07-24 | N/A | $0.13 | — |
| 2025-04-29 | N/A | $0.13 | — |
Dividend History
Yield
0.01%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| May 02, 2025 | May 27, 2025 | $0.17 | 1.01% |
| Apr 29, 2024 | — | $0.13 | 0.78% |
| May 01, 2023 | — | $0.13 | 0.80% |
| Apr 28, 2022 | May 23, 2022 | $0.12 | 0.75% |
| Apr 30, 2021 | — | $0.09 | 0.74% |
Key Takeaways
Revenue grew 14.63% annually over 5 years — strong growth
Earnings grew 364.07% over the past year
ROE of 15.54% — decent returns on equity
Debt/Equity of 2.70 — high leverage
Generating 185.60M in free cash flow
P/E of 32.18 — premium valuation
Growth
Revenue Growth (5Y)
14.63%
Revenue (1Y)13.69%
Earnings (1Y)364.07%
FCF Growth (3Y)40.14%
Quality
Return on Equity
15.54%
ROIC5.92%
Net Margin3.26%
Op. Margin6.55%
Safety
Debt / Equity
2.70
Current Ratio0.70
Interest Coverage2.43
Valuation
P/E Ratio
32.18
Forward P/EN/A
P/B Ratio4.68
EV/EBITDA24.74
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13.69% | Revenue Growth (3Y) | 16.69% |
| Earnings Growth (1Y) | 364.07% | Earnings Growth (3Y) | 109.84% |
| Revenue Growth (5Y) | 14.63% | Earnings Growth (5Y) | -6.59% |
| Profitability | |||
| Revenue (TTM) | 2.38B | Net Income (TTM) | 77.50M |
| ROE | 15.54% | ROA | 3.20% |
| Gross Margin | 23.16% | Operating Margin | 6.55% |
| Net Margin | 3.26% | Free Cash Flow (TTM) | 185.60M |
| ROIC | 5.92% | FCF Growth (3Y) | 40.14% |
| Safety | |||
| Debt / Equity | 2.70 | Current Ratio | 0.70 |
| Interest Coverage | 2.43 | ||
| Dividends | |||
| Dividend Yield | 0.01% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 32.18 | Forward P/E | N/A |
| P/B Ratio | 4.68 | P/S Ratio | 1.05 |
| PEG Ratio | 0.08 | Forward PEG | N/A |
| EV/EBITDA | 24.74 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 7.44% | ||
| Market Cap | 2.49B | Enterprise Value | 3.85B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.38B | 2.09B | 1.75B | 1.51B | 1.38B |
| Net Income | 77.50M | 16.70M | 17.60M | 11.80M | 101.80M |
| EPS (Diluted) | 0.51 | 0.11 | 0.12 | 0.08 | 0.69 |
| Gross Profit | 550.70M | 448.30M | 359.40M | 335.30M | 395.00M |
| Operating Income | 155.70M | 70.30M | 61.40M | 55.20M | 159.40M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.42B | 2.14B | 1.94B | 1.83B | 1.68B |
| Total Liabilities | 1.88B | 1.65B | 1.41B | 1.32B | 1.12B |
| Shareholders' Equity | 532.80M | 464.80M | 496.50M | 472.40M | 517.60M |
| Total Debt | 1.44B | 1.24B | 1.00B | 940.00M | 764.10M |
| Cash & Equivalents | 82.30M | 69.80M | 50.80M | 40.40M | 81.90M |
| Current Assets | 496.50M | 446.70M | 381.30M | 334.20M | 551.60M |
| Current Liabilities | 707.70M | 566.30M | 500.60M | 356.40M | 325.00M |